Padagis
Develops and manufactures generic prescription topical pharmaceutical products.
Company facts
- Founded
- 2004
- Employees
- 1,300
- Headquarters
- United States
- CEO
- Pamela Hoffman
- Type
- Private
- Funding
- Private Equity · $1.6B · 2021
- Subsidiaries
- Padagis Israel
About
At Padagis, we are dedicated to expanding access to high-quality, affordable medications that support better health outcomes. Founded with the vision that every patient deserves affordable access to the medication that best serves their needs, we have grown into a leading global provider of generic pharmaceuticals. Our dedicated team, operating across the U.S. and Israel, is committed to innovation and excellence, ensuring that our products meet rigorous safety and efficacy standards while remaining accessible to all. With a focus on topical and other non-oral pharmaceutical products, we manufacture a broad range of prescription and over-the-counter treatments including prescription creams, ointments, gels, foams, sprays, patches, nasal treatments, and suppositories. We specialize in Paragraph IV products, developing and manufacturing treatments that focus on the complexities of branded pharmaceutical patents. Padagis is at the forefront of reducing healthcare costs and improving accessibility, with a strong focus on life-saving products like Naloxone Nasal Spray to combat the opioid crisis. Our commitment to innovation, reliability, and reducing healthcare costs helps patients and healthcare providers get the care they need with confidence.